Cardium Therapeutics Incorporation operates in the Biological products exc. diagnostic sector. Cardium Therapeutics, Inc. (Cardium) is a development-stage company. Cardium's business is focused on the acquisition and strategic development of product opportunities or businesses having the potential to address unmet medical needs. In November 2010, the Company announced the launch of its MedPodiumTM healthy lifestyle product platform and Web boutique. With additional products and distribution channels, the Company plans to develop MedPodium into a portfolio of science-based, easy to use medicinals, neurologics, metabolics, nutraceuticals and aesthetics intended to promote and manage personal health. In November 2010, the Company launched MedPodium, which is a healthy lifestyle product line and Web boutique. In
our complete report available for purchase the company is compared to: Novavax, Inc., Neuralstem, Incorporation. and Genta Inc.